Do you have what it takes to climb into the C-Suite? If you make it there will you stay? A recent study shows that for every woman at the director level who gets promoted, two women directors are choosing to leave their company. Join us as we share our suspicions as to why. Give WISEcast some monthly listener support or make a one-time donation →Paypal.
Rachel Diamant is the co-founder and Chief Business Officer of Emendo Biotherapeutics, a next-generation gene editing company that targets genes with unprecedented levels of precision and efficacy. Operating in a field that is largely dominated by men, Rachel has emerged as a true innovator and leader, helping to position Emendo as a key player that is set to disrupt the landscape of gene therapies in the coming years. Rachel drives Emendo’s strategy, science, and clinical programs essential to positioning Emendo as an attractive opportunity for investors and partners alike. Rachel holds an MSc in Neurobiology from the Weizmann Institute of Science and a Biotechnology Engineering degree from the Technion Israel Institute of Technology.
WISEcast is featured as one of the top 10 podcasts from the 60 Best Women in STEM Podcasts by Feedspot! Check out The Wisest Children on YouTube and see how our young scientist proteges are making science accessible and fun through some STEM activities for kids! You can connect with us on: Instagram, Facebook, Twitter, YouTube, LinkedIn or by email at thewisestwomen@gmail.com.
